ID   MARK1_HUMAN             Reviewed;         795 AA.
AC   Q9P0L2; Q2HIY1; Q5VTF9; Q5VTG0; Q96SW9; Q9P251;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   05-OCT-2010, entry version 91.
DE   RecName: Full=Serine/threonine-protein kinase MARK1;
DE            EC=2.7.11.1;
DE   AltName: Full=MAP/microtubule affinity-regulating kinase 1;
GN   Name=MARK1; Synonyms=KIAA1477, MARK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-215, AND MUTAGENESIS OF THR-215.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zhou H.J., Huang X.W., Zhou Y., Hu S.L., Yuan J.G., Qiang B.Q.;
RT   "Cloning and isolating human MARK.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   MEDLINE=20277482; PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=97262070; PubMed=9108484; DOI=10.1016/S0092-8674(00)80208-1;
RA   Drewes G., Ebneth A., Preuss U., Mandelkow E.-M., Mandelkow E.;
RT   "MARK - a novel family of protein kinases that phosphorylate
RT   microtubule-associated proteins and trigger microtubule disruption.";
RL   Cell 89:297-308(1997).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-649, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-588 AND THR-598, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-5; SER-46; THR-215;
RP   SER-219; SER-403; SER-423; SER-475; SER-588 AND SER-633, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-588 AND THR-596, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-463; SER-468; SER-470;
RP   SER-475; SER-588 AND SER-633, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 45-371.
RX   PubMed=16803889; DOI=10.1074/jbc.M604865200;
RA   Marx A., Nugoor C., Muller J., Panneerselvam S., Timm T., Bilang M.,
RA   Mylonas E., Svergun D.I., Mandelkow E.M., Mandelkow E.;
RT   "Structural variations in the catalytic and ubiquitin-associated
RT   domains of microtubule-associated protein/microtubule affinity
RT   regulating kinase (MARK) 1 and MARK2.";
RL   J. Biol. Chem. 281:27586-27599(2006).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-233; THR-355; MET-530; LEU-578 AND
RP   GLY-691.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in cytoskeletal stability (By
CC       similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-215 by
CC       STK11 in complex with STE20-related adapter-alpha (STRAD alpha)
CC       pseudo kinase and CAB39.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton (By similarity).
CC       Note=Appears to localize to an intracellular network (By
CC       similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P0L2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P0L2-2; Sequence=VSP_051702, VSP_051704;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q9P0L2-3; Sequence=VSP_051703, VSP_051704;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle,
CC       brain, fetal brain and fetal kidney.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. MARK subfamily.
CC   -!- SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA96001.1; Type=Erroneous initiation;
CC       Sequence=BAB55152.1; Type=Frameshift; Positions=763;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF154845; AAF72103.1; -; mRNA.
DR   EMBL; AB040910; BAA96001.1; ALT_INIT; mRNA.
DR   EMBL; AK027493; BAB55152.1; ALT_FRAME; mRNA.
DR   EMBL; AL592406; CAH72462.1; -; Genomic_DNA.
DR   EMBL; AC096640; CAH72462.1; JOINED; Genomic_DNA.
DR   EMBL; AL592406; CAH72463.1; -; Genomic_DNA.
DR   EMBL; AC096640; CAH72463.1; JOINED; Genomic_DNA.
DR   EMBL; BC113869; AAI13870.1; -; mRNA.
DR   EMBL; BC114478; AAI14479.1; -; mRNA.
DR   IPI; IPI00185037; -.
DR   IPI; IPI00292809; -.
DR   IPI; IPI00555711; -.
DR   RefSeq; NP_061120.3; -.
DR   UniGene; Hs.497806; -.
DR   PDB; 2HAK; X-ray; 2.60 A; A/B/C/D/E/F/G/H=45-371.
DR   PDBsum; 2HAK; -.
DR   ProteinModelPortal; Q9P0L2; -.
DR   SMR; Q9P0L2; 695-795.
DR   IntAct; Q9P0L2; 9.
DR   MINT; MINT-3975018; -.
DR   STRING; Q9P0L2; -.
DR   PhosphoSite; Q9P0L2; -.
DR   PRIDE; Q9P0L2; -.
DR   Ensembl; ENST00000366917; ENSP00000355884; ENSG00000116141.
DR   GeneID; 4139; -.
DR   KEGG; hsa:4139; -.
DR   NMPDR; fig|9606.3.peg.3095; -.
DR   UCSC; uc001hmm.2; human.
DR   UCSC; uc001hmn.2; human.
DR   UCSC; uc001hmo.2; human.
DR   CTD; 4139; -.
DR   GeneCards; GC01P220701; -.
DR   H-InvDB; HIX0001604; -.
DR   HGNC; HGNC:6896; MARK1.
DR   HPA; HPA007421; -.
DR   HPA; HPA008061; -.
DR   MIM; 606511; gene.
DR   PharmGKB; PA30639; -.
DR   eggNOG; prNOG11513; -.
DR   HOGENOM; HBG315019; -.
DR   HOVERGEN; HBG052453; -.
DR   InParanoid; Q9P0L2; -.
DR   OMA; TRPRHQK; -.
DR   OrthoDB; EOG9GTNZC; -.
DR   PhylomeDB; Q9P0L2; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 16256; -.
DR   ArrayExpress; Q9P0L2; -.
DR   Bgee; Q9P0L2; -.
DR   CleanEx; HS_MARK1; -.
DR   Genevestigator; Q9P0L2; -.
DR   GermOnline; ENSG00000116141; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR001772; Kinase-assoc_KA1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020670; MAP/microtub-affin-reg_kin2/4.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF55; MAP/microtub-affin-reg_kin2/4; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    795       Serine/threonine-protein kinase MARK1.
FT                                /FTId=PRO_0000086298.
FT   DOMAIN       60    311       Protein kinase.
FT   DOMAIN      325    370       UBA.
FT   DOMAIN      746    795       KA1.
FT   NP_BIND      66     74       ATP (By similarity).
FT   ACT_SITE    182    182       Proton acceptor (By similarity).
FT   BINDING      89     89       ATP (By similarity).
FT   MOD_RES       5      5       Phosphothreonine.
FT   MOD_RES      46     46       Phosphoserine.
FT   MOD_RES     215    215       Phosphothreonine.
FT   MOD_RES     219    219       Phosphoserine.
FT   MOD_RES     394    394       Phosphoserine (By similarity).
FT   MOD_RES     403    403       Phosphoserine.
FT   MOD_RES     423    423       Phosphoserine.
FT   MOD_RES     463    463       Phosphoserine.
FT   MOD_RES     468    468       Phosphoserine.
FT   MOD_RES     470    470       Phosphoserine.
FT   MOD_RES     475    475       Phosphoserine.
FT   MOD_RES     588    588       Phosphoserine.
FT   MOD_RES     596    596       Phosphothreonine.
FT   MOD_RES     633    633       Phosphoserine.
FT   MOD_RES     649    649       Phosphoserine.
FT   MOD_RES     666    666       Phosphoserine (By similarity).
FT   VAR_SEQ       1    135       Missing (in isoform 2).
FT                                /FTId=VSP_051702.
FT   VAR_SEQ     120    141       Missing (in isoform 3).
FT                                /FTId=VSP_051703.
FT   VAR_SEQ     663    677       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_051704.
FT   VARIANT     233    233       Y -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040760.
FT   VARIANT     355    355       N -> T (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040761.
FT   VARIANT     530    530       V -> M (in dbSNP:rs56212551).
FT                                /FTId=VAR_040762.
FT   VARIANT     578    578       P -> L (in dbSNP:rs55691439).
FT                                /FTId=VAR_040763.
FT   VARIANT     645    645       R -> G (in dbSNP:rs12123778).
FT                                /FTId=VAR_030018.
FT   VARIANT     691    691       E -> G (in dbSNP:rs55688276).
FT                                /FTId=VAR_040764.
FT   MUTAGEN     215    215       T->A: Prevents phosphorylation and
FT                                activation by STK11 complex.
FT   MUTAGEN     215    215       T->E: Constitutively active.
FT   CONFLICT     16     16       E -> V (in Ref. 2; AAF72103).
FT   CONFLICT     20     20       S -> T (in Ref. 2; AAF72103).
FT   CONFLICT    522    522       D -> N (in Ref. 4; BAB55152).
FT   CONFLICT    544    544       V -> A (in Ref. 4; BAB55152).
FT   CONFLICT    763    763       P -> A (in Ref. 4; BAB55152).
FT   CONFLICT    794    794       K -> M (in Ref. 3; BAA96001).
FT   STRAND       60     68
FT   STRAND       70     79
FT   TURN         80     82
FT   STRAND       85     92
FT   HELIX        98    113
FT   STRAND      122    127
FT   STRAND      129    136
FT   HELIX       144    151
FT   HELIX       156    176
FT   HELIX       185    187
FT   STRAND      188    190
FT   STRAND      196    198
FT   STRAND      221    223
FT   HELIX       225    229
FT   HELIX       236    252
FT   HELIX       262    271
FT   HELIX       282    291
FT   HELIX       296    298
FT   HELIX       302    306
FT   HELIX       309    312
FT   STRAND      316    318
FT   HELIX       333    342
FT   HELIX       346    354
FT   HELIX       360    367
SQ   SEQUENCE   795 AA;  89003 MW;  71BF6EB76912631B CRC64;
     MSARTPLPTV NERDTENHTS VDGYTEPHIQ PTKSSSRQNI PRCRNSITSA TDEQPHIGNY
     RLQKTIGKGN FAKVKLARHV LTGREVAVKI IDKTQLNPTS LQKLFREVRI MKILNHPNIV
     KLFEVIETEK TLYLVMEYAS GGEVFDYLVA HGRMKEKEAR AKFRQIVSAV QYCHQKYIVH
     RDLKAENLLL DGDMNIKIAD FGFSNEFTVG NKLDTFCGSP PYAAPELFQG KKYDGPEVDV
     WSLGVILYTL VSGSLPFDGQ NLKELRERVL RGKYRIPFYM STDCENLLKK LLVLNPIKRG
     SLEQIMKDRW MNVGHEEEEL KPYTEPDPDF NDTKRIDIMV TMGFARDEIN DALINQKYDE
     VMATYILLGR KPPEFEGGES LSSGNLCQRS RPSSDLNNST LQSPAHLKVQ RSISANQKQR
     RFSDHAGPSI PPAVSYTKRP QANSVESEQK EEWDKDVARK LGSTTVGSKS EMTASPLVGP
     ERKKSSTIPS NNVYSGGSMA RRNTYVCERT TDRYVALQNG KDSSLTEMSV SSISSAGSSV
     ASAVPSARPR HQKSMSTSGH PIKVTLPTIK DGSEAYRPGT TQRVPAASPS AHSISTATPD
     RTRFPRGSSS RSTFHGEQLR ERRSVAYNGP PASPSHETGA FAHARRGTST GIISKITSKF
     VRRDPSEGEA SGRTDTSRST SGEPKERDKE EGKDSKPRSL RFTWSMKTTS SMDPNDMMRE
     IRKVLDANNC DYEQKERFLL FCVHGDARQD SLVQWEMEVC KLPRLSLNGV RFKRISGTSI
     AFKNIASKIA NELKL
//
